These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Sympathetic Transduction in Type 2 Diabetes Mellitus. Young BE; Holwerda SW; Vranish JR; Keller DM; Fadel PJ Hypertension; 2019 Jul; 74(1):201-207. PubMed ID: 31188673 [TBL] [Abstract][Full Text] [Related]
10. The activity of single vasoconstrictor nerve units in hypertension. Mary DA; Stoker JB Acta Physiol Scand; 2003 Mar; 177(3):367-76. PubMed ID: 12609008 [TBL] [Abstract][Full Text] [Related]
11. Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis. Grassi G; D'Arrigo G; Pisano A; Bolignano D; Mallamaci F; Dell'Oro R; Quarti-Trevano F; Seravalle G; Mancia G; Zoccali C J Hypertens; 2019 Sep; 37(9):1746-1756. PubMed ID: 30950979 [TBL] [Abstract][Full Text] [Related]
12. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Huggett RJ; Scott EM; Gilbey SG; Stoker JB; Mackintosh AF; Mary DA Circulation; 2003 Dec; 108(25):3097-101. PubMed ID: 14676139 [TBL] [Abstract][Full Text] [Related]
13. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure. Notarius CF; Butler GC; Ando S; Pollard MJ; Senn BL; Floras JS Clin Sci (Lond); 1999 Jun; 96(6):557-65. PubMed ID: 10334961 [TBL] [Abstract][Full Text] [Related]
14. Augmented pressor and sympathetic responses to skeletal muscle metaboreflex activation in type 2 diabetes patients. Holwerda SW; Restaino RM; Manrique C; Lastra G; Fisher JP; Fadel PJ Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H300-9. PubMed ID: 26566729 [TBL] [Abstract][Full Text] [Related]
15. Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes. Kolodziejski PA; Pruszynska-Oszmalek E; Sassek M; Kaczmarek P; Szczepankiewicz D; Billert M; Mackowiak P; Strowski MZ; Nowak KW J Diabetes; 2017 Apr; 9(4):353-361. PubMed ID: 27106635 [TBL] [Abstract][Full Text] [Related]
16. Neuroadrenergic activation in obstructive sleep apnoea syndrome: a new selected meta-analysis - revisited. Biffi A; Quarti-Trevano F; Bonzani M; Seravalle G; Corrao G; Mancia G; Grassi G J Hypertens; 2022 Jan; 40(1):15-23. PubMed ID: 34857700 [TBL] [Abstract][Full Text] [Related]
17. Sympathetic nervous system, diabetes, and hypertension. Perin PC; Maule S; Quadri R Clin Exp Hypertens; 2001; 23(1-2):45-55. PubMed ID: 11270588 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar. Alyafei F; Soliman A; Alkhalaf F; Sabt A; De Sanctis V; Elsayed N; Waseef R Acta Biomed; 2018 May; 89(S5):32-39. PubMed ID: 30049930 [TBL] [Abstract][Full Text] [Related]
20. Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension. Grassi G; Seravalle G; Brambilla G; Pini C; Alimento M; Facchetti R; Spaziani D; Cuspidi C; Mancia G Int J Cardiol; 2014 Dec; 177(3):1020-5. PubMed ID: 25449517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]